What is LOPJLB’s current signal on RNAC?

LOPJLB’s latest quantitative signal on Cartesian Therapeutics, Inc. (RNAC) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is RNAC in?

Cartesian Therapeutics, Inc. (RNAC) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Cartesian Therapeutics, Inc. (RNAC) do?

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The companyâs lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune dis…

Where is Cartesian Therapeutics, Inc. based / listed?

Cartesian Therapeutics, Inc. is based in US, listed on NASDAQ.

Cartesian Therapeutics, Inc. (RNAC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$7.06+3.52%Close

SELLCRISIS · day 22

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $207M
Beta: 0.62
P/E (TTM): -1.14

Short % float: 17.46%
Days to cover: 12.6
SI change: +2.9%

1W: -4.08%
1M: -16.25%

vs SPY 1W: -5.24%
vs SPY 1M: -19.24%

Industry peers

FMP comparable companies · ranked by market cap

AVTXSELLAvalo Therapeutics, Inc.$718MCRISISQ -10$13.65+1.64%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news